MSF responds to malaria emergencies in Ethiopia

George Mapiye, MSF Deputy medical Coordinator in Ethiopia, talking about MSF's effort to minimize impact of malaria on the South Sudanese refugee communities, in Kule Refugee Camp, Gambella Region of Ethiopia.

MSB215752

To Report An Asset

If you think this image is in any way inappropriate, please report it, by including its URN/identifying code and a brief description of your concern in sending an email to [email protected]

Linked assets

PDF

MSB215152.pdf

PDF

MSB214005.pdf

MSF responds to malaria emergencies in Ethiopia

No Subtitles (international)

Kule_Gambella _R21 Malaria Vaccine

Add to lightbox

Add to cart

Unique Identifier Code / URN MSB215752

Date taken / Date Recorded 17/10/2024 12:00 AM

Expiration date 17/10/2029

Country Ethiopia

Commissioning section MSF-NETHERLANDS

Photographer / videographer / producer Metasebia Teshome

Copyright MSF

Usage Rights (MSF) Advertising Campaign, External Media, MSF Fundraising, MSF Publications, Social Media

Formal Consent Copy available yes

Editor's rating ★★★ (F)

Video format h264 (Main) (avc1 / 0x31637661)

Duration 1m22s

Maximum Size 1080px × 1920px 102.69 MB

Additional Information / Shotlist The Kule refugee camp, located in the Gambella region, hosts over 50,000 refugees from South Sudan and experiences a seasonal malaria peak every year. In 2024, MSF health facility has seen a 150% increase in malaria cases compared to the previous years. MSF working in close collaboration with local and regional actors, introduced a ‘comprehensive/consolidated’ malaria operational plan comprising of health promotion and community engagement, environmental control measures, vector control measures (Indoor residual spraying), decentralised malaria diagnosis, treatment and referral points. In addition, MSF introduced and provided IPTc (Intermittent Preventative Treatment in Children), and the new WHO approved malaria r21 vaccine to specific age group.